Dr. Frank F Davidson, M.D. Internal Medicine - Pulmonary Disease Medicare: Not Enrolled in Medicare Practice Location: 20 Hope Ave, Waltham, MA 02453 Phone: 781-893-3163 |
News Archive
Cancer survivors die of non-cancer-related causes at much higher rates than the general public. In 2008, the U.S. economic burden of cancer totaled over $228 billion but only 41% of these costs involved direct cancer care. The majority of expenses were attributed to increased morbidity, lost productivity, and premature mortality.
Constant infusion of a drug now used intermittently to "rescue" patients with Parkinson's from bouts of immobility may also help avoid these debilitating symptoms and smooth out their movement throughout the day, physician-scientists say.
Acetylon Pharmaceuticals, Inc., the leader in the development of selective histone deacetylase (HDAC) inhibitors for enhanced therapeutic outcomes, announced that positive preclinical data for its selective HDAC1/2 inhibitors for the treatment of sickle cell disease (SCD) and β-thalassemia (bT) were presented at the 55th Annual Meeting of the American Society of Hematology (ASH) in New Orleans, LA.
The New York Times: "Dr. Harold E. Varmus, a Nobel Prize-winning biologist and former director of the National Institutes of Health, will become director of the National Cancer Institute, the White House announced Monday. President Obama selected Dr. Varmus, who is now president of Memorial Sloan-Kettering Cancer Center in New York, after a lengthy search. Dr. Varmus is expected to shake up the much-criticized federal cancer program" (Pear, 5/17).
› Verified 4 days ago